Shares of Actinium Pharmaceuticals Inc. ATNM, +39.16% were up 22.8% in trading on Monday after the company met the primary endpoint in a Phase 3 clinical trial for its investigational treatment for re...
Shares of Actinium Pharmaceuticals Inc. ATNM, +39.16% were up 22.8% in trading on Monday after the company met the primary endpoint in a Phase 3 clinical trial for its investigational treatment for re...